Back to search

Article

SS-31 Reverses Mitochondrial Fragmentation in Fibroblasts from Patients with DCMA, a Mitochondrial Cardiomyopathy

2019-06-17

Abstract excerpt

<h4>ABSTRACT</h4> <h4>Objectives</h4> We used patient dermal fibroblasts to characterize the mitochondrial abnormalities associated with the dilated cardiomyopathy with ataxia syndrome (DCMA) and to study the effect of the mitochondrially-targeted peptide SS-31 as a potential novel therapeutic. <h4>Background</h4> DCMA is an understudied autosomal recessive disorder thought to be related to Barth syndrome but c...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
49c9171d-f849-540a-9b22-f7fe115236ff
DOI
10.1101/672857
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
SS-31 Reverses Mitochondrial Fragmentation in Fibroblasts from Patients with DCMA, a Mitochondrial CardiomyopathyDOI 10.1101/672857
Select a neighboring publication to make it the new centre.